“…The renal excretion of intravenous cholegraphic agents can be estimated by observing the incidence of urinary tract visualisation on the radiographs (Darnborough and Geffen, 1966;Nolan and Gibson, 1970;Masterson, 1973). However, it has been shown that the presence or absence of urinary tract visualisation during intravenous cholegraphy only partly reflects the urinary concentration of contrast and gives no indication of total excretion or of excretion rates (Theander, 1956).…”
SUMMARY A new method for measuring the urinary concentration of meglumine ioglycamide, a radiological contrast agent, is described. The contrast is precipitated with acid, redissolved, and estimated by ultraviolet spectrophotometry.
“…The renal excretion of intravenous cholegraphic agents can be estimated by observing the incidence of urinary tract visualisation on the radiographs (Darnborough and Geffen, 1966;Nolan and Gibson, 1970;Masterson, 1973). However, it has been shown that the presence or absence of urinary tract visualisation during intravenous cholegraphy only partly reflects the urinary concentration of contrast and gives no indication of total excretion or of excretion rates (Theander, 1956).…”
SUMMARY A new method for measuring the urinary concentration of meglumine ioglycamide, a radiological contrast agent, is described. The contrast is precipitated with acid, redissolved, and estimated by ultraviolet spectrophotometry.
“…Simultaneous hepatic and renal excretion frequently occurred without evidence of liver disease and with satisfactory demonstration of the biliary tract. Also THEANDER (1956) has found that visualization of the renal pelvis does indicate hepato-biliary disease.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.